Q2 FY2026 EarningsQ2 FY2026 beat consensus on both top and bottom lines: revenue $1.39B vs. $1.37B expected, and adjusted EPS $0.15 vs. $0.16 (in-line with rounding; GAAP EPS -$0.04 beat -$0.05 mean). Surgical segment led growth with a 19% YoY reported increase, driven by premium IOLs. Full-year FY26 revenue guidance was raised to $5.44B-$5.54B, slightly above the midpoint of previous market expectations, signaling sustained momentum in the dry eye franchise.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Bausch + Lomb(BLCO) the Revenue is 1.394 B (+9.08%), Beat estimate;the EBIT is 171 M (+12.5%), Beat estimate;the EPS is -0.04 (+77.78%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
1.39B9.08%
1.37B7.06%
+0.03B2.02%
EBITExceed expectations
0.17B12.50%
0.16B6.60%
+0.01B5.90%
EPSMiss expectations
-0.0477.78%
-0.037179.41%
-0.00291.63%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf